EUVIMEDEUVIMED entdecken
Crossref

Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation

Kazuya Kinoshita, Michihiro Maruyama, Masaya Yokoyama, Takeshi Toyozumi, Yasunori Matsumoto, Ryota Otsuka, Nobufumi Sekino, Soichiro Hirasawa, Takuma Sasaki, Hiroki Morishita, Shinichiro Iida, Yuri Nishioka und 2 weitere

Transplant Immunology · 2026

DOI: 10.1016/j.trim.2026.102418 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Immunology, 2026. Verfasst von Kazuya Kinoshita und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Thiophenes, Glucosides, Diabetes Mellitus, Experimental. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sodium-glucose cotransporter 2 (SGLT2) inhibitors lower blood glucose by promoting urinary glucose excretion and also exert anti-inflammatory and organ-protective effects. This study examined the effects of short-term peri-operative SGLT2 inhibition with ipragliflozin on islet transplantation in a mouse model of diabetes. Streptozotocin-induced diabetic mice underwent portal vein islet transplantation and received either ipragliflozin (Tx + Ip, n = 16) or no treatment (Tx, n = 16) during the perioperative period. At 4 weeks after transplantation, outcomes assessed included blood glucose normalization, body weight, glucose tolerance, insulin secretion, and hepatic expression of inflammatory markers and islet-specific genes. The Tx + Ip group showed a higher rate of blood glucose normalization (75% vs. 25%, p < 0.05), improved glucose tolerance, and higher fasting insulin levels compared with the Tx group. Early hepatic expression of inflammatory markers (tumor growth factor-β, interferon-γ, and interleukin-6) was lower in the Tx + Ip group, whereas expression of the islet survival gene Pdx1 was higher on day 5, suggesting enhanced islet engraftment. These findings indicate that short-term perioperative ipragliflozin improves islet transplantation outcomes in diabetic mice by attenuating early inflammation and supporting islet survival and function, with potential translational relevance for clinical islet transplantation strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Islets of Langerhans TransplantationThiophenesGlucosidesDiabetes Mellitus, ExperimentalSodium-Glucose Transporter 2 InhibitorsIslets of LangerhansAnimalsMiceMaleBlood GlucoseGraft SurvivalInsulinSodium-Glucose Transporter 2Homeodomain ProteinsMice, Inbred C57BLHumans

Stichwörter der Autor:innen

Anti-inflammatoryIBMIRIpragliflozinIslet transplantationSGLT2 inhibitor

Substanzen

ipragliflozinThiophenesGlucosidesSodium-Glucose Transporter 2 InhibitorsBlood GlucoseInsulinSodium-Glucose Transporter 2Homeodomain Proteins

Autor:innen und Institutionen

  • Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.
  • Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan. Electronic address: michi-maruyama@chiba-u.jp.
  • Department of Frontier Surgery, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan; Sammu Medical Center, 250 Narutō, Sanmu, Chiba 289-1326, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Kinoshita, K., Maruyama, M., Yokoyama, M., Toyozumi, T., Matsumoto, Y., Otsuka, R., Sekino, N., Hirasawa, S., Sasaki, T., Morishita, H., Iida, S., Nishioka, Y., Iida, K., & Matsubara, H. (2026). Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation. Transplant Immunology. https://doi.org/10.1016/j.trim.2026.102418

Vancouver

Kinoshita K, Maruyama M, Yokoyama M, Toyozumi T, Matsumoto Y, Otsuka R, et al. Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation. Transplant Immunology. 2026. doi:10.1016/j.trim.2026.102418

BibTeX
@article{Kinoshita2026,
  author = {Kinoshita, Kazuya and Maruyama, Michihiro and Yokoyama, Masaya and Toyozumi, Takeshi and Matsumoto, Yasunori and Otsuka, Ryota and Sekino, Nobufumi and Hirasawa, Soichiro and Sasaki, Takuma and Morishita, Hiroki and Iida, Shinichiro and Nishioka, Yuri and Iida, Keiko and Matsubara, Hisahiro},
  title = {Short-term sodium-glucose cotransporter 2 inhibition with ipragliflozin enhances engraftment and function in murine islet transplantation},
  journal = {Transplant Immunology},
  year = {2026},
  doi = {10.1016/j.trim.2026.102418}
}
Kostenlos starten →